ITA 104, a product of antiplatelet aggregation activity
Bruseghini, L.; Vilageliu, J.
Archivos de Farmacologia y Toxicologia 4(1): 132-134
1978
ISSN/ISBN: 0304-8616 PMID: 697378 Document Number: 125402
Document emailed within 1 workday
Related Documents
Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472Guha, S.; Sardar, P.; Guha, P.; Deb, S.; Karmakar, R.; Chakraborti, P.; Mookerjee, S.; Deb, P.K.; De, R.; Dutta, A.; Chaudhuri, U. 2009: Dual antiplatelet therapy in ACS: time-dependent variability in platelet aggregation during the first week Indian Heart Journal 61(2): 173-177
Wang, Y.-m.; Cao, Y.-j.; Liu, C.-f.; Feng, P. 2007: The changes and effects of antiplatelet agents on platelet-leukocyte aggregation in patients with acute cerebral infarction Zhonghua Nei Ke Za Zhi 46(7): 562-565
Momo, K.; Someya, K.; Tachiiri, T.; Mitsuoka, Y.; Nakamura, K.; Imai, S.; Ino, T.; Ohkubo, H. 1992: Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals Arzneimittel-Forschung 42(1): 32-39
Iioka, H.; Hisanaga, H.; Moriyama, I.; Akasaki, M.; Nabuchi, K.; Katakami, Y.; Katoh, Y.; Ichijo, M. 1989: The study on the platelet aggregation inhibition activity of placental brush border (the mechanism of platelet aggregation inhibition) Nihon Sanka Fujinka Gakkai Zasshi 41(12): 1916-1920
Spasov, A.A.; Kucheriavenko, A.F.; Anisimova, V.A. 2014: Calcium-depended mechanism of the antiplatelet activity of benzimidazole derivative RU-891 Eksperimental'naia i Klinicheskaia Farmakologiia 77(3): 16-19
Celestini, A.; Pulcinelli, F.M.; Pignatelli, P.; Lenti, L.; Frati, G.; Gazzaniga, P.Paolo.; Violi, F. 2002: Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets Haematologica 87(4): 420-426
Ferroni, R.; Simoni, D.; Orlandini, P.; Bardi, A.; Franze, G.P.; Guarneri, M. 1990: Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones Arzneimittel-Forschung 40(12): 1328-1331
Iioka, H.; Hisanaga, H.; Akada, S.; Moriyama, I.; Ichijo, M. 1992: The platelet aggregation inhibiting activity in human placenta--study on the ADP degrading activity of human placental villi Nihon Sanka Fujinka Gakkai Zasshi 44(6): 631-637
Desvignes, A.; Bernard, J. 1984: Determination of bactericidal activity of a product containing an antiseptic Annales Pharmaceutiques Francaises 42(6): 581-587
Muslimova, E.F.; Afanasiev, S.A.; Rebrova, T.Yu.; Sergienko, T.N.; Repin, A.N. 2017: Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy Terapevticheskii Arkhiv 89(5): 74-78
Harris, P.J. 1982: Neutrophil product with lymphocyte activating factor activity Clinical and Experimental Immunology 50(3): 474-478
Chiariello, M.; Piacenza, G.; Pesce, E. 1978: In vitro anti-aggregation activity of Ozopulmin Bollettino Chimico Farmaceutico 117(9): 549-552
Quagliata, F.; Beckerdite-Quagliata, S.; Russo, C.; Bisno, A.; Indiveri, F.; Pellegrino, M.; Ferrone, S. 1981: Induction of Ia-like antigens by a group a streptococcal product with mitogenic activity Transplantation Proceedings 13(1 Part 2): 1049-1050
Shimokhina, N.I.; Petrova, M.M.; Savchenko, A.A. 2010: Aggregation activity of platelets in various periods of ischemic stroke Kardiologiia 50(8): 21-24
Apukhovskaia, L.I.; Vendt, V.P. 1972: Study of the biological activity of the vitamin D3 conversion product in bone tissue Prikladnaia Biokhimiia i Mikrobiologiia 8(6): 849-853
Chatterjie, N.; Sinha, B.; Alexander, G.J. 1983: Synthesis and anticonvulsive activity of a N-propylurea-ninhydrin condensation product in mice Research Communications in Chemical Pathology and Pharmacology 39(2): 333-336
Mungiu, O.C.; Ionescu, G.D.; Antohie, C.; Dragomir, B.; Cotrutz, C. 1993: Pharmacotoxicological studies of a natural plant product in the PT series. I. the chronic toxicity of the product PT 2A Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 97(2): 323-327
Romano, J.W.; Van Damme, L.; Hillier, S. 2014: The future of multipurpose prevention technology product strategies: understanding the market in parallel with product development Bjog: An International Journal of Obstetrics and Gynaecology 121 Suppl. 5: 15-18
Losonczy, H.; Nagy, I.; Szaksz, I. 1979: Effect of bencyclan and theophylline on changes of platelet aggregation and factor 3 activity Folia Haematologica 106(5-6): 853-860